Aerogen involved in cutting edge project focused on improving the treatment of antibiotic-resistant pneumonia.

News
20th January 2020

The FAIR project has formally began following the team’s first meeting in Paris, France on the 13-14 January, 2020.

The FAIR project will focus on improving the treatment of antibiotic-resistant pneumonia. This has the potential to provide huge benefits on a worldwide scale.

It will receive a total of €10 million in funding from EU Horizon 2020 grants over five years, beginning in January 2020 until December 2024.

Ronan MacLoughlin is the lead from Aerogen on this project.  

Read more here

More News & Events